论文信息 - Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes - 字舞流文

Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes

Anup D. Patel | Laurie E. Seltzer | J. Szaflarski | D. Friedman | O. Devinsky | E. Thiele | L. Laux | A. Wilfong | E. Bebin | G. Clark | F. Filloux | R. Flamini | R. Wechsler | C. Verducci | Yong D. Park | Gary D. Clark